Rubric Capital Management (New York)’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.1M Buy
2024
Q3
Sell
2024
Q2
$6.86M Hold
2024
Q1
$5.73M Buy